Dr. Martens (LON:DOCS) Stock Price Up 14.3% - Still a Buy?

Dr. Martens plc (LON:DOCS - Get Free Report) shares traded up 14.3% on Thursday . The stock traded as high as GBX 71 ($0.96) and last traded at GBX 68.55 ($0.93). 4,561,156 shares were traded during mid-day trading, an increase of 106% from the average session volume of 2,218,223 shares. The stock had previously closed at GBX 59.95 ($0.81).

Analyst Upgrades and Downgrades

Separately, Royal Bank of Canada cut their price objective on shares of Dr. Martens from GBX 7,000 ($94.70) to GBX 6,000 ($81.17) and set a "sector perform" rating on the stock in a research report on Monday, May 19th.

Dr. Martens Trading Up 8.7%

The company has a debt-to-equity ratio of 127.27, a current ratio of 2.85 and a quick ratio of 1.13. The firm has a fifty day simple moving average of GBX 54.73 and a 200-day simple moving average of GBX 62.64. The firm has a market cap of £795.54 million, a P/E ratio of 11.62, a price-to-earnings-growth ratio of 6.40 and a beta of 0.11.

Dr. Martens (LON:DOCS - Get Free Report) last posted its quarterly earnings results on Thursday, June 5th. The company reported GBX 2.40 ($0.03) earnings per share (EPS) for the quarter. Dr. Martens had a net margin of 7.89% and a return on equity of 18.91%. On average, equities research analysts expect that Dr. Martens plc will post 2.5809394 earnings per share for the current year.

Dr. Martens Cuts Dividend

The firm also recently disclosed a dividend, which was paid on Tuesday, April 8th. Stockholders of record on Thursday, March 6th were issued a dividend of GBX 0.85 ($0.01) per share. This represents a dividend yield of 1.47%. The ex-dividend date was Thursday, March 6th. Dr. Martens's dividend payout ratio is currently 42.53%.

Insider Buying and Selling

In other news, insider Giles Wilson purchased 32,640 shares of the company's stock in a transaction that occurred on Tuesday, March 25th. The shares were bought at an average cost of GBX 54 ($0.73) per share, with a total value of £17,625.60 ($23,844.16). Insiders have acquired 33,206 shares of company stock worth $1,792,771 in the last quarter. Insiders own 4.36% of the company's stock.

About Dr. Martens

Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage and, six decades later, “Docs” or “DMs” are worn by people around the world who use them as a symbol of empowerment and their own individual attitude. The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and is a constituent of the FTSE 250 index.